Your selections:
Prostate-specific antigen response to androgen deprivation therapy in the neoadjuvant setting for high-risk prostate adenocarcinoma (PIRANHA): Pooled analysis of two randomized clinical trials
- Nikitas, John, Ong, Wee Loon, Carrier, Nathalie, Romero, Tahmineh, Millar, Jeremy, Steinberg, Michael L., Rettig, Matthew B., Boutros, Paul C., Reiter, Robert, Nickols, Nicholas G., Valle, Luca, McGuire, Sean E., Spratt, Daniel E., Souhami, Luis, Roy, Soumyajit, Martin, Jarad M., Joseph, David, Nabid, Abdenour, Kishan, Amar U.
- Bandara, Vindya, Capp, Anne, Ahmed, Gias, Arm, Jameen, Martin, Jarrad
Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer
- Taaffe, Dennis R., Buffart, Laurien M., Newton, Robert U., Spry, Nigel, Denham, James, Joseph, David, Lamb, David, Chambers, Suzanne K., Galvão, Daniel A.
- Warren, Laura E. G., Chen, Ming-Hui, Denham, James W., Steigler, Allison B., Renshaw, Andrew A., Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.
- Lehman, Margot, Hayden, Amy J., Martin, Jarad M., Christie, David, Kneebone, Andrew B., Sidhom, Mark, Skala, Marketa, Tai, Keen-Hun
- Lehman, Margot, Sidhom, Mark, Kneebone, Andrew B., Hayden, Amy J., Martin, Jarad M., Christie, David, Skala, Marketa, Tai, Keen-Hun
- Wilcox, Chantelle, Kautto, Allison, Steigler, Allison, Denham, James W.
Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?
- Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Cormie, Prue, Chambers, Suzanne K., Gardiner, Robert A., Shum, David H. K., Joseph, David, Galvao, Daniel A.
Are you sure you would like to clear your session, including search history and login status?